Morphea and other localized forms of scleroderma

Rebecca Vasquez, Chelsea Sendejo, Heidi Jacobe

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Purpose of Review: Morphea, also known as localized scleroderma, is a disorder of excessive collagen deposition leading to thickening of the dermis and/or subcutaneous tissues and may cause significant morbidity. This review will describe new developments in the evaluation and management of morphea as well as its pathophysiology. The reader will be able to apply these findings to patient management. Recent Findings: The recent development of validated outcome measures (i.e. the localized scleroderma cutaneous assessment tool) as well as consensus treatment recommendations provide a platform for collaboration among specialties to develop both standardized assessment tools and therapeutic trials. New studies have also begun to investigate the immunological underpinnings of morphea. Summary: The promise of evidence-based treatments for morphea in the near future will provide better care for patients with morphea and understanding its pathophysiology will lay groundwork for the development of new treatments.

Original languageEnglish (US)
Pages (from-to)685-693
Number of pages9
JournalCurrent Opinion in Rheumatology
Volume24
Issue number6
DOIs
StatePublished - Nov 2012

Fingerprint

Localized Scleroderma
Subcutaneous Tissue
Therapeutics
Dermis
Patient Care
Collagen
Outcome Assessment (Health Care)
Morbidity
Skin

Keywords

  • localized scleroderma
  • morphea
  • outcome measures
  • treatment

ASJC Scopus subject areas

  • Rheumatology

Cite this

Morphea and other localized forms of scleroderma. / Vasquez, Rebecca; Sendejo, Chelsea; Jacobe, Heidi.

In: Current Opinion in Rheumatology, Vol. 24, No. 6, 11.2012, p. 685-693.

Research output: Contribution to journalArticle

@article{f095736f7ee6497dbfbae6e16f1e2a04,
title = "Morphea and other localized forms of scleroderma",
abstract = "Purpose of Review: Morphea, also known as localized scleroderma, is a disorder of excessive collagen deposition leading to thickening of the dermis and/or subcutaneous tissues and may cause significant morbidity. This review will describe new developments in the evaluation and management of morphea as well as its pathophysiology. The reader will be able to apply these findings to patient management. Recent Findings: The recent development of validated outcome measures (i.e. the localized scleroderma cutaneous assessment tool) as well as consensus treatment recommendations provide a platform for collaboration among specialties to develop both standardized assessment tools and therapeutic trials. New studies have also begun to investigate the immunological underpinnings of morphea. Summary: The promise of evidence-based treatments for morphea in the near future will provide better care for patients with morphea and understanding its pathophysiology will lay groundwork for the development of new treatments.",
keywords = "localized scleroderma, morphea, outcome measures, treatment",
author = "Rebecca Vasquez and Chelsea Sendejo and Heidi Jacobe",
year = "2012",
month = "11",
doi = "10.1097/BOR.0b013e32835896ce",
language = "English (US)",
volume = "24",
pages = "685--693",
journal = "Current Opinion in Rheumatology",
issn = "1040-8711",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Morphea and other localized forms of scleroderma

AU - Vasquez, Rebecca

AU - Sendejo, Chelsea

AU - Jacobe, Heidi

PY - 2012/11

Y1 - 2012/11

N2 - Purpose of Review: Morphea, also known as localized scleroderma, is a disorder of excessive collagen deposition leading to thickening of the dermis and/or subcutaneous tissues and may cause significant morbidity. This review will describe new developments in the evaluation and management of morphea as well as its pathophysiology. The reader will be able to apply these findings to patient management. Recent Findings: The recent development of validated outcome measures (i.e. the localized scleroderma cutaneous assessment tool) as well as consensus treatment recommendations provide a platform for collaboration among specialties to develop both standardized assessment tools and therapeutic trials. New studies have also begun to investigate the immunological underpinnings of morphea. Summary: The promise of evidence-based treatments for morphea in the near future will provide better care for patients with morphea and understanding its pathophysiology will lay groundwork for the development of new treatments.

AB - Purpose of Review: Morphea, also known as localized scleroderma, is a disorder of excessive collagen deposition leading to thickening of the dermis and/or subcutaneous tissues and may cause significant morbidity. This review will describe new developments in the evaluation and management of morphea as well as its pathophysiology. The reader will be able to apply these findings to patient management. Recent Findings: The recent development of validated outcome measures (i.e. the localized scleroderma cutaneous assessment tool) as well as consensus treatment recommendations provide a platform for collaboration among specialties to develop both standardized assessment tools and therapeutic trials. New studies have also begun to investigate the immunological underpinnings of morphea. Summary: The promise of evidence-based treatments for morphea in the near future will provide better care for patients with morphea and understanding its pathophysiology will lay groundwork for the development of new treatments.

KW - localized scleroderma

KW - morphea

KW - outcome measures

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=84866992318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866992318&partnerID=8YFLogxK

U2 - 10.1097/BOR.0b013e32835896ce

DO - 10.1097/BOR.0b013e32835896ce

M3 - Article

C2 - 23018858

AN - SCOPUS:84866992318

VL - 24

SP - 685

EP - 693

JO - Current Opinion in Rheumatology

JF - Current Opinion in Rheumatology

SN - 1040-8711

IS - 6

ER -